x
Filter:
Filters applied
- Immunization
- LetterRemove Letter filter
- Review ArticleRemove Review Article filter
- Rapid CommunicationRemove Rapid Communication filter
- 2020 - 2022Remove 2020 - 2022 filter
Author
- Guo, Xianwei2
- Sun, Chenyu2
- Adashi, Eli Y1
- Akintobi, Tabia1
- Bednarczyk, Robert A1
- Bentley, Rachel1
- Chauhan, Aparna V1
- Costello, Amy A1
- Creary, Susan E1
- Cruse, Bradley1
- Davis, David1
- DeBlasio, Dominick J1
- Ding, Xiuxiu1
- Dombkowski, Kevin J1
- Feng, Linya1
- Freed, Gary L1
- Gao, Juan1
- Gruppuso, Philip A1
- Guo, Zhichun1
- Haderlein, Taona P1
- Hiban, Kayli M1
- Hill, Holly A1
- Hong, Kai1
- Horvitz-Lennon, Marcela1
- Jones, Kenneth T1
Immunization
The research in this collection illustrates the cumulative impact vaccines have on the health and well-being of entire and diverse populations. It includes studies on vaccine cost-effectiveness, vaccine coverage disparities, and immunization policy, management and education.
11 Results
- Review Article
A Systematic Review and Meta-analysis of the Association Between SARS-CoV-2 Vaccination and Myocarditis or Pericarditis
American Journal of Preventive MedicineVol. 64Issue 2p275–284Published online: September 25, 2022- Juan Gao
- Linya Feng
- Yaru Li
- Scott Lowe
- Zhichun Guo
- Rachel Bentley
- and others
Cited in Scopus: 0There have been reports of potential negative cardiovascular effects from the COVID-19 vaccine, such as myocarditis or pericarditis. This study sought to ascertain the risk of myocarditis/pericarditis after COVID-19 vaccination by conducting an extensive meta-analysis of published cases. - Research Brief
COVID-19 Booster Vaccination in the U.S. Military, August 2021–January 2022
American Journal of Preventive MedicineVol. 64Issue 2p270–274Published online: August 28, 2022- Erin L. Winkler
- Shauna L. Stahlman
- Natalie Y. Wells
- Aparna V. Chauhan
- Kayli M. Hiban
- Amy A. Costello
- and others
Cited in Scopus: 0A booster dose of messenger RNA vaccine protects against severe COVID-19 outcomes. This study examined the incidence of COVID-19 booster vaccination among active-duty U.S. military servicemembers between August 2021 and January 2022, factors associated with vaccination uptake, and trends over time. - Current Issues
Intranasal SARS-CoV-2 Vaccines: Indispensable and Inevitable
American Journal of Preventive MedicineVol. 63Issue 6p1062–1063Published online: July 10, 2022- Eli Y. Adashi
- Philip A. Gruppuso
Cited in Scopus: 0Their extraordinary efficacy notwithstanding, the parenterally administered mRNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have proven incapable of preventing breakthrough infections in otherwise fully vaccinated subjects.1 Interpersonal transmission of SARS-CoV-2 through respiratory droplets and aerosols by fully vaccinated subjects has also proven resistant to vaccine-induced immunity.1 These relative shortcomings of the parenterally administered mRNA vaccines are hardly unanticipated because upper airway protection against SARS-CoV-2 replication and shedding requires local mucosal rather than systemic humoral immunity. - Topics in Education
Impact of a Virtual Reality Curriculum on Human Papillomavirus Vaccination: A Pilot Trial
American Journal of Preventive MedicineVol. 63Issue 5p865–873Published online: June 28, 2022- Francis J. Real
- Nicholas J. Ollberding
- Andrea R. Meisman
- Dominick J. DeBlasio
- Mary Beth Pero
- David Davis
- and others
Cited in Scopus: 0Although the strongest predictor of human papillomavirus (HPV) vaccination is a high-quality recommendation, physicians often provide weak recommendations. Thus, the authors developed Virtual Immersive Communication Training on Recommending Immunizations (VICTORI), a virtual reality (VR)‒based intervention that provided physicians the opportunity to deliberately practice recommendation behaviors. VICTORI included VR simulations during which participants counseled caregiver avatars hesitant to vaccinate. - Research Brief
Vaccination Coverage of Privately Insured Children: Comparing U.S. Survey and Administrative Data
American Journal of Preventive MedicineVol. 63Issue 1p107–110Published online: March 19, 2022- Kai Hong
- Holly A. Hill
- Yuping Tsai
- Megan C. Lindley
- Fangjun Zhou
Cited in Scopus: 0National Immunization Survey-Child data are used widely to assess childhood vaccination coverage in the U.S. This study compares National Immunization Survey-Child coverage estimates with estimates using other supplementary data sources. - Review Article
The Association Between Previous Influenza Vaccination and COVID-19 Infection Risk and Severity: A Systematic Review and Meta-analysis
American Journal of Preventive MedicineVol. 63Issue 1p121–130Published online: March 14, 2022- Wanying Su
- Hao Wang
- Chenyu Sun
- Ning Li
- Xianwei Guo
- Qiuxia Song
- and others
Cited in Scopus: 11The association between influenza vaccination and COVID-19 remains controversial. This meta-analysis aimed to investigate whether influenza vaccination reduces the susceptibility and severity of SARS-CoV-2 infection. - RESEARCH LETTER
COVID-19 Vaccination: Concerning Trends in Primary Care Health Professional Shortage Areas
American Journal of Preventive MedicineVol. 63Issue 1e31–e33Published online: February 8, 2022- Hao Yu
- Michael Klompas
- Aaron Kofner
- Marcela Horvitz-Lennon
- Fang Zhang
- Susan McKernan
Cited in Scopus: 0Widespread vaccination is the most promising way to control the coronavirus disease 2019 (COVID-19) pandemic. Unfortunately, U.S. vaccination rates have stagnated. The rates are particularly low among racial/ethnic minority groups1 and rural residents.2 Although much of the discussion about low vaccination centers on person-level factors, the role of healthcare system factors is not well understood. An important system factor is the availability of primary care physicians, who play an integral role in counseling patients regarding the risks and benefits of vaccination. - Research Brief
High-Grade Vulvar, Vaginal, and Anal Precancers Among U.S. Adolescents and Young Adults After Human Papillomavirus Vaccine Introduction
American Journal of Preventive MedicineVol. 62Issue 1p95–99Published in issue: January, 2022- Jacqueline M. Mix
- Mona Saraiya
- Virginia Senkomago
- Elizabeth R. Unger
Cited in Scopus: 1Since human papillomavirus vaccine introduction, incidence rates of cervical precancers have decreased; however, the vaccine's impact on noncervical anogenital precancers has not been shown. These precancers are identified opportunistically and are not collected routinely by most cancer registries. - Research Brief
Racial/Ethnic Variation in Veterans Health Administration COVID-19 Vaccine Uptake
American Journal of Preventive MedicineVol. 62Issue 4p596–601Published online: October 20, 2021- Taona P. Haderlein
- Michelle S. Wong
- Kenneth T. Jones
- Ernest M. Moy
- Anita H. Yuan
- Donna L. Washington
Cited in Scopus: 6Equitable COVID-19 vaccine access is imperative to mitigating negative COVID-19 impacts among racial/ethnic minorities. U.S. racial/ethnic minorities have lower COVID-19 vaccination rates than Whites despite higher COVID-19 death/case rates. The Veterans Health Administration provides the unique context of a managed care system with few access barriers. This study evaluates race/ethnicity as a predictor of Veterans Health Administration COVID-19 vaccination. - Research Letter
Demographic Benchmarks for Equitable Coverage of COVID-19 Vaccination
American Journal of Preventive MedicineVol. 61Issue 2p291–293Published online: April 28, 2021- Kushagra Vashist
- Tabia Akintobi
- Robert A. Bednarczyk
- K.M. Venkat Narayan
- Shivani A. Patel
Cited in Scopus: 0After a year of unprecedented social distancing and >530,000 American deaths due to coronavirus disease 2019 (COVID-19), 3 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are authorized for emergency use. Federal and state authorities based vaccination priorities on employment in high-exposure occupations essential to everyday life and on vulnerability to severe COVID-19 disease.1 By virtue of employment in high-exposure occupations2 and experience of severe COVID-19 disease and death,3 people of color—especially Black, Hispanic, and Native Americans—are expected to be prioritized for early vaccination. - Research Brief
Primary Immunization Series Coverage of Children With Sickle Cell Disease
American Journal of Preventive MedicineVol. 61Issue 1p124–127Published online: March 11, 2021- Hannah K. Peng
- Kevin J. Dombkowski
- Gary L. Freed
- Susan E. Creary
- Dominic Smith
- Sarah L. Reeves
Cited in Scopus: 0Children with sickle cell disease are at increased risk of serious infections, many of which can be prevented by receipt of recommended immunizations. Study objectives were to (1) assess the primary immunization series coverage among children with sickle cell disease and (2) compare the coverage with that of those without sickle cell disease.